NDC11 70518454500
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70518-4545-0 | 70518-4545 |
| 70518-4545-00 | 70518-4545 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Terazosin | TERAZOSIN | REMEDYREPACK INC. | a16abe41-98e7-4e60-8c1b-911c6a29f0a2 | 2026-01-14 | Warnings, Adverse reactions | 70518-4545-0 70518-4545 70518454500 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.